Matching slides 58,039
Current window 31,141-31,170
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all

Slide function

31,141-31,170 of 58,039

filter-aware
18
The table displays N, sex, age, weight, race, ethnicity, and surgical status for placebo and three treatment arms.9 Meters Biopharma | Investor Presentation Deck | 30 slides · 9 Meters Biopharma
Pitch deck Investor relations 1 hit
19
The chart compares placebo, 50 mg Q2W, 50 mg weekly, and 100 mg Q2W groups, highlighting percentage decreases relative to the placebo increase.9 Meters Biopharma | Investor Presentation Deck | 30 slides · 9 Meters Biopharma
Pitch deck Investor relations Beat · Traction1 hit
26
The table displays counts of specific adverse events (Nausea, Vomiting, etc.) across four study arms.9 Meters Biopharma | Investor Presentation Deck | 30 slides · 9 Meters Biopharma
Pitch deck Investor relations 1 hit
05
The H1 2021 chart shows a very high concentration in Germany (94%), while H1 2022 shows significant diversification.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Humble OriginsLoop · Before After1 hit
07
Contains a typo in 'Reserach and development expenses'.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
08
Values are in kEUR.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
09
The table displays financial figures in kEUR, comparing two half-year periods.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
11
The slide uses a split-column layout to contrast two business segments' ability to pass through inflation costs.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The slide uses a structured table-like layout with bar charts to compare year-over-year performance.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations Beat · Traction1 hit
16
The chart uses a standard waterfall bridge format to reconcile EBITDA to FCF.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations Beat · Financials1 hit
18
Includes a debt maturity chart and detailed breakdown of debt instruments and equity components.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
21
Includes footnotes 1-9 referenced in the table rows.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
22
The slide presents two separate tables for Sales and Marketing segments, detailing various add-backs and adjustments to arrive at Adjusted EBITDA.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
23
This is a standard financial disclosure slide showing historical EBITDA adjustments.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
24
Contains two distinct tables for Sales Segment and Marketing Segment reconciliation.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
25
The slide provides a breakdown of debt components and cash to arrive at a net debt figure.Advantage Solutions | Investor Presentation Deck | 26 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
13
The slide uses a table-like structure to categorize performance drivers by product segment.AgroFresh | Investor Conference Presentation Deck | 20 slides · AgroFresh
Conference presentation Investor relations Loop · Why Now1 hit
14
AgroFresh | Investor Conference Presentation Deck | 20 slidesAgroFresh | Investor Conference Presentation Deck | 20 slides · AgroFresh
Conference presentation Investor relations Beat · FinancialsLoop · Why Now1 hit
15
Includes footnotes explaining non-recurring items and reconciliation references.AgroFresh | Investor Conference Presentation Deck | 20 slides · AgroFresh
Conference presentation Investor relations Beat · Financials1 hit
19
Standard financial disclosure slide for non-GAAP measures.AgroFresh | Investor Conference Presentation Deck | 20 slides · AgroFresh
Conference presentation Investor relations 1 hit
20
Standard financial disclosure slide for non-GAAP metrics.AgroFresh | Investor Conference Presentation Deck | 20 slides · AgroFresh
Conference presentation Investor relations 1 hit
14
Includes footnotes referencing LTM data and reconciliation.AgroFresh | Investor Presentation Deck | 20 slides · AgroFresh
Pitch deck Investor relations 1 hit
19
Contains two separate reconciliation tables with corresponding footnotes.AgroFresh | Investor Presentation Deck | 20 slides · AgroFresh
Pitch deck Investor relations 1 hit
20
Standard financial disclosure slide for non-GAAP metrics.AgroFresh | Investor Presentation Deck | 20 slides · AgroFresh
Pitch deck Investor relations 1 hit
08
The slide highlights clinical validation across 47 trials, split between prospective Phase 2 and retrospective Phase 2/3 studies.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
10
The slide demonstrates the predictive power of the DRP biomarker by contrasting the entire study population (no benefit) with the DRP-selected subgroup (significant benefit).Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
14
The slide uses a box plot to show the distribution of DRP scores between clinical responders and non-responders, with a clear cutoff at 50.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
40
The table compares two financial scenarios side-by-side for years 1, 5, and 10.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
41
Includes specific financial targets for energy sold, revenue, and EBITDA.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
46
Includes a background image of a person in a car, likely branding or lifestyle imagery.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit